BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 28619234)

  • 1. What is the heterogeneity in the impact seen with pneumococcal conjugate vaccines telling us?
    Hausdorff WP; Black S
    Vaccine; 2017 Jul; 35(31):3797-3800. PubMed ID: 28619234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pneumococcal vaccination for children and adults].
    Albrich W
    Ther Umsch; 2016; 73(5):235-40. PubMed ID: 27268445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pneumococcal conjugate vaccine for young children.
    Selman S; Hayes D; Perin LA; Hayes WS
    Manag Care; 2000 Sep; 9(9):49-52, 54, 56-7 passim. PubMed ID: 11116663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic resistance and the potential impact of pneumococcal conjugate vaccines.
    Dagan R
    Commun Dis Intell Q Rep; 2003; 27 Suppl():S134-42. PubMed ID: 12807290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pneumococcal Disease in the Era of Pneumococcal Conjugate Vaccine.
    Yildirim I; Shea KM; Pelton SI
    Infect Dis Clin North Am; 2015 Dec; 29(4):679-97. PubMed ID: 26610421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impacts of the 13-Valent Pneumococcal Conjugate Vaccine in Children.
    Esposito S; Principi N
    J Immunol Res; 2015; 2015():591580. PubMed ID: 26351648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of pneumococcal disease in children. Pneumococcal conjugate vaccines: their use globally could have a major impact on public health.
    Kyaw MH; Jones IG; Campbell H
    Acta Paediatr; 2001 May; 90(5):473-6. PubMed ID: 11430703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting the impact of new pneumococcal conjugate vaccines: serotype composition is not enough.
    Hausdorff WP; Hoet B; Adegbola RA
    Expert Rev Vaccines; 2015 Mar; 14(3):413-28. PubMed ID: 25266168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pneumococcal vaccines for children: a global public health priority.
    Pittet LF; Posfay-Barbe KM
    Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():25-36. PubMed ID: 22862432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pneumococcal conjugate vaccine introduction in Latin America and the Caribbean: progress and lessons learned.
    de Oliveira LH; Trumbo SP; Ruiz Matus C; Sanwogou NJ; Toscano CM
    Expert Rev Vaccines; 2016 Oct; 15(10):1295-304. PubMed ID: 26982434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letter from the Editor: pneumococcal conjugate vaccine.
    Ellis R
    Hum Vaccin Immunother; 2014; 10(9):2754. PubMed ID: 25483629
    [No Abstract]   [Full Text] [Related]  

  • 12. Challenges in estimating the impact of pneumococcal conjugate vaccines through surveillance.
    Vergison A; Hanquet G
    Pediatr Infect Dis J; 2012 Apr; 31(4):400-3. PubMed ID: 22418653
    [No Abstract]   [Full Text] [Related]  

  • 13. Pneumococcal vaccine for adults.
    Med Lett Drugs Ther; 2012 Oct; 54(1402):87-8. PubMed ID: 23114739
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of pneumococcal conjugate vaccines for children in high- and non-high-income countries.
    Cohen R; Cohen JF; Chalumeau M; Levy C
    Expert Rev Vaccines; 2017 Jun; 16(6):625-640. PubMed ID: 28409537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of conjugate pneumococcal vaccines on the changing epidemiology of pneumococcal infections.
    Zangeneh TT; Baracco G; Al-Tawfiq JA
    Expert Rev Vaccines; 2011 Mar; 10(3):345-53. PubMed ID: 21434802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of conjugate pneumococcal vaccination in Singapore: comparing estimates for 7-valent, 10-valent, and 13-valent vaccines.
    Tyo KR; Rosen MM; Zeng W; Yap M; Pwee KH; Ang LW; Shepard DS
    Vaccine; 2011 Sep; 29(38):6686-94. PubMed ID: 21745516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of pneumococcal conjugate vaccines on otitis media-can we extrapolate to pneumonia?
    Dagan R
    Vaccine; 2008 Jun; 26 Suppl 2():B16-8. PubMed ID: 18793601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience with pneumococcal polysaccharide conjugate vaccine (conjugated to CRM197 carrier protein) in children and adults.
    Durando P; Faust SN; Fletcher M; Krizova P; Torres A; Welte T
    Clin Microbiol Infect; 2013 Oct; 19 Suppl 1():1-9. PubMed ID: 24083785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pneumococcal vaccines for infants and children--past, present, and future.
    Klein JO
    Curr Clin Top Infect Dis; 2002; 22():252-65. PubMed ID: 12520657
    [No Abstract]   [Full Text] [Related]  

  • 20. Interim results of an ecological experiment - Conjugate vaccination against the pneumococcus and serotype replacement.
    Hausdorff WP; Hanage WP
    Hum Vaccin Immunother; 2016; 12(2):358-74. PubMed ID: 26905681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.